0001567619-20-020348.txt : 20201125 0001567619-20-020348.hdr.sgml : 20201125 20201125121554 ACCESSION NUMBER: 0001567619-20-020348 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201125 DATE AS OF CHANGE: 20201125 EFFECTIVENESS DATE: 20201125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GLO Pharma, Inc. CENTRAL INDEX KEY: 0001832546 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-381518 FILM NUMBER: 201348700 BUSINESS ADDRESS: STREET 1: 315 SOUTH COAST HIGHWAY 101 STREET 2: SUITE U290 CITY: ENCINITAS STATE: CA ZIP: 92024 BUSINESS PHONE: (833) 456-7546 MAIL ADDRESS: STREET 1: 315 SOUTH COAST HIGHWAY 101 STREET 2: SUITE U290 CITY: ENCINITAS STATE: CA ZIP: 92024 D 1 primary_doc.xml X0708 D LIVE 0001832546 GLO Pharma, Inc. 315 South Coast Highway 101 Suite U290 Encinitas CA CALIFORNIA 92024 (833) 456-7546 DELAWARE None None Corporation true 2018 Scott Glenn 315 South Coast Highway 101 Suite U290 Encinitas CA CALIFORNIA 92024 Executive Officer Director Lauren Otsuki 315 South Coast Highway 101 Suite U290 Encinitas CA CALIFORNIA 92024 Director Jana Messersmith 315 South Coast Highway 101 Suite U290 Encinitas CA CALIFORNIA 92024 Director Todd Jackson 315 South Coast Highway 101 Suite U290 Encinitas CA CALIFORNIA 92024 Director Pharmaceuticals Decline to Disclose 06b false 2020-11-12 false true false 0 511000 511000 0 Reflects stock issued in connection with the conversion from a limited liability company to a corporation. false 22 0 0 0 false GLO Pharma, Inc. /s/ Scott Glenn Scott Glenn CEO, President, Treasurer and Secretary 2020-11-23